or Try an Advanced Search...

    Lymphocytes Stocks List

    Symbol Grade Name % Change
    INDP F Indaptus Therapeutics, Inc. -1.42
    NKGN F NKGen Biotech, Inc. 5.43
    IOVA F Iovance Biotherapeutics, Inc. 2.27
    TIL D Instil Bio, Inc. 5.91
    GRI D GRI Bio, Inc. 4.99
    CELU C Celularity Inc. -5.78
    IBRX C ImmunityBio, Inc. 4.72
    GDTC C CytoMed Therapeutics Limited -0.46
    TGTX B TG Therapeutics, Inc. 11.64
    View As Page of Charts
    Related Industries: Biotechnology Conglomerates
    Related Stock Lists: Immune System Cancer Medicine Natural Killer Cell Cancer Immunotherapy Cell Therapy Clinical Medicine Immunotherapy Biopharmaceutical Cancer Treatment Virotherapy Biotechnology Melanoma Oncology Stem Cell Tumor Infiltrating Lymphocytes Adoptive Cell Transfer Antibody Drug Conjugate Antibody Therapy Antineoplastic Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Lymphocytes stocks.

    Symbol Grade Name Weight
    BBP C BioShares Biotechnology Products Fund 4.25
    PBE D PowerShares Dynamic Biotech & Genome 3.78
    IDNA D iShares Genomics Immunology and Healthcare ETF 3.22
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 2.64
    XBI D SPDR S&P Biotech ETF 2.5
    View all Lymphocytes ETFs...
    Compare ETFs
    Compare BBP to PBE Compare PBE to PSCH Compare PSCH to XBI

        Lymphocytes Stocks Recent News

        Date Stock Title
        Nov 21 GRI GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
        Nov 21 TGTX TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
        Nov 20 IBRX High Growth Tech Stocks To Watch In November 2024
        Nov 20 CELU Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
        Nov 20 GDTC Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies
        Nov 19 IBRX ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months
        Nov 18 CELU Celularity announces resolution of Nasdaq listing compliance matter
        Nov 18 CELU Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
        Nov 15 TIL Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy
        Nov 15 GRI GRI Bio reports 9M results
        Nov 14 GRI GRI Bio files to sell 1.58M shares of common stock for holders
        Nov 14 GRI GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis
        Related Industries: Biotechnology Conglomerates
        Related Stock Lists: Immune System Cancer Medicine Natural Killer Cell Cancer Immunotherapy Cell Therapy Clinical Medicine Immunotherapy Biopharmaceutical Cancer Treatment Virotherapy Biotechnology Melanoma Oncology Stem Cell Tumor Infiltrating Lymphocytes Adoptive Cell Transfer Antibody Drug Conjugate Antibody Therapy Antineoplastic Drugs
        Lymphocytes

        A lymphocyte is a type of white blood cell in the vertebrate immune system. Lymphocytes include natural killer cells (which function in cell-mediated, cytotoxic innate immunity), T cells (for cell-mediated, cytotoxic adaptive immunity), and B cells (for humoral, antibody-driven adaptive immunity). They are the main type of cell found in lymph, which prompted the name "lymphocyte".Lymphocytes make up between 18% and 42% of circulating leukocytes.

        More about Lymphocytes
        Browse All Tags